Cirque Lodge Studio
-
Services:
- Prescribes naltrexone
- Relapse prevention with naltrexone
- Lofexidine or Clonidine detoxification
- Prescribes buprenorphine
- Adult women
- Clients with co-occurring mental and substance use disorders
- Adult men
- Smoking permitted in designated area
- Cocaine Detoxification
- Medication routinely used during detoxification
- Opioids detoxification
- Methamphetamines detoxification
- Benzodiazepines Detoxification
- Alcohol Detoxification
- Complete medical history/physical exam
- Comprehensive substance use assessment
- Screening for mental disorders
- Outreach to persons in the community
- Screening for tobacco use
- Comprehensive mental health assessment
- Screening for substance use
- Long-term residential
- Short-term residential
- Residential/24-hour residential
- Residential detoxification
- Outcome follow-up after discharge
- Discharge Planning
- Naloxone and overdose education
- Aftercare/continuing care
- Vaping permitted in designated area
- Other contracted prescribing entity
- Female
- Male
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Detoxification
- Substance use treatment
- Cash or self-payment
- Private health insurance
- Self-help groups
- Recovery coach
- Housing services
- Employment counseling or training
- 12-step facilitation
- Brief intervention
- Motivational interviewing
- Cognitive behavioral therapy
- Substance use disorder counseling
- Relapse prevention
- Anger management
- Telemedicine/telehealth therapy
- Trauma-related counseling
- Hepatitis B (HBV) vaccination
- Hepatitis A (HAV) vaccination
- Marital/couples counseling
- Family counseling
- Substance use disorder education
- Health education services other than HIV/AIDS or hepatitis
- Group counseling
- Individual counseling
- Smoking/vaping/tobacco cessation counseling
- This facility administers/prescribes medication for alcohol use disorder
- Mental health services
- Integrated primary care services
- Suicide prevention services
- Private for-profit organization
- TB screening
- HIV testing
- Breathalyzer or blood alcohol testing
- Testing for Hepatitis C (HCV)
- Metabolic syndrome monitoring
- STD testing
- Testing for Hepatitis B (HBV)
- Drug or alcohol urine screening
- Buprenorphine with naloxone
- Clonidine
- Medications for pre-exposure to prophylaxis
- Buprenorphine (extended-release, injectable)
- Naltrexone (extended-release, injectable)
- Acamprosate (Campral®)
- Medications for Hepatitis C treatment
- Medications for HIV treatment
- Disulfiram
- Non-nicotine smoking/tobacco cessation
- Nicotine replacement
- Naltrexone (oral)
- Medication for mental disorders
- Treatment for gambling disorder
- The Joint Commission
- State department of health
- Young Adults
- Adults
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
Type of Opioid Treatment
Special Programs/Groups Offered
Facility Smoking Policy
Detoxification (medical withdrawal) Services
Assessment/Pre-treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Transitional Services
Facility Vaping Policy
External Source of Medications Used for Alcohol Use Disorder Treatment
Gender Accepted
Type of Care
Payment/Insurance/Funding Accepted
Recovery Support Services
Treatment Approaches
Medical Services
Education and Counseling Services
Type of Alcohol Use Disorder Treatment
Ancillary Services
Facility Operation (e.g., Private, Public)
Testing
Pharmacotherapies
Other Services
License/Certification/Accreditation
Age Groups Accepted
Opioid Medications used in Treatment